Managed Healthcare Executive"/> Managed Healthcare Executive"/> Managed Healthcare Executive"/>
Full article view 2017-09-21T12:08:00+00:00
Back to News & Insights »

Schafer Talks "One and Done" Gene Therapy Treatments With Managed Healthcare Executive

 

Tracy Walker from Managed Healthcare Executive talks with Precision for Value’s Jeremy Schafer regarding Kymriah, the first gene therapy approved for cancer treatment. Schafer flags the challenges facing payers in support of this new generation of therapies. He cites the unique outcomes-based arrangement between Novartis and CMS as one example of how manufacturers are navigating the complex landscape.

To read the complete article, please click here.

 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.